• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患儿急性呼吸衰竭时,血浆表面活性剂蛋白 D 与肺泡上皮损伤生物标志物的相关性,与患者体重状况相关。

Association of patient weight status with plasma surfactant protein D, a biomarker of alveolar epithelial injury, in children with acute respiratory failure.

机构信息

Division of Critical Care, Department of Pediatrics, UCSF Benioff Children's Hospitals, San Francisco and Oakland, California.

Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan.

出版信息

Pediatr Pulmonol. 2020 Oct;55(10):2730-2736. doi: 10.1002/ppul.24990. Epub 2020 Aug 7.

DOI:10.1002/ppul.24990
PMID:32725941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8087214/
Abstract

AIMS AND OBJECTIVES

Alveolar epithelial injury is a key determinant of acute respiratory failure (ARF) severity. Plasma surfactant protein D (SP-D), a biomarker of alveolar epithelial injury, is lower in obese adults with ARF compared to their lean peers. We aimed to determine if children with ARF have similar variance in plasma SP-D associated with their weight status on admission.

METHODS

Plasma SP-D was measured on days 0, 1, or 2 in children (1-18 years) with ARF enrolled in the genetic variation and biomarkers in children with acute lung injury and RESTORE studies. Weight classification (underweight, normal, overweight, and obese) was based on body mass index or weight-for-height z-scores. Associations between weight group and SP-D on each day were tested.

RESULTS

Inclusion criteria were met in 212 subjects, 24% were obese. There were no differences among weight groups in SP-D levels on days 0 and 1. However, on day 2, there was a statistically significant linear trend for lower SP-D levels as weight increased in both the univariate analysis (P = .02) and when adjusting for age, ethnicity, and diagnosis of pediatric acute respiratory distress syndrome (P = .05).

CONCLUSIONS

Obesity was associated with lower plasma SP-D levels on day 2 of ARF. This finding may be explained by altered ARF pathogenesis in obese individuals or a reduced incidence of ventilator-induced lung injury.

摘要

目的和目标

肺泡上皮损伤是急性呼吸衰竭(ARF)严重程度的关键决定因素。血浆表面活性剂蛋白 D(SP-D)是肺泡上皮损伤的生物标志物,与瘦体型的同龄人相比,肥胖的 ARF 成年患者血浆 SP-D 水平较低。我们旨在确定 ARF 患儿在入院时的体重状况是否与血浆 SP-D 存在类似的差异。

方法

在基因变异和儿童急性肺损伤生物标志物研究(genetic variation and biomarkers in children with acute lung injury and RESTORE studies)中,对患有 ARF 的儿童(1-18 岁)在入院后第 0、1 或 2 天测量血浆 SP-D。体重分类(体重不足、正常、超重和肥胖)基于体重指数或体重与身高的 z 评分。在每天的体重组和 SP-D 之间测试关联。

结果

212 名符合纳入标准的受试者中,24%为肥胖。在第 0 天和第 1 天,体重组之间的 SP-D 水平没有差异。然而,在第 2 天,在单变量分析(P=.02)和调整年龄、种族和儿科急性呼吸窘迫综合征诊断(P=.05)后,SP-D 水平随着体重增加呈统计学上显著的线性趋势。

结论

肥胖与 ARF 第 2 天的血浆 SP-D 水平较低有关。这一发现可能是由于肥胖个体的 ARF 发病机制改变或呼吸机引起的肺损伤发生率降低所致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce2/8087214/538a7910086a/nihms-1644035-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce2/8087214/b6e2fc32acd3/nihms-1644035-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce2/8087214/538a7910086a/nihms-1644035-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce2/8087214/b6e2fc32acd3/nihms-1644035-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce2/8087214/538a7910086a/nihms-1644035-f0002.jpg

相似文献

1
Association of patient weight status with plasma surfactant protein D, a biomarker of alveolar epithelial injury, in children with acute respiratory failure.患儿急性呼吸衰竭时,血浆表面活性剂蛋白 D 与肺泡上皮损伤生物标志物的相关性,与患者体重状况相关。
Pediatr Pulmonol. 2020 Oct;55(10):2730-2736. doi: 10.1002/ppul.24990. Epub 2020 Aug 7.
2
Surfactant Protein D Is Associated With Severe Pediatric ARDS, Prolonged Ventilation, and Death in Children With Acute Respiratory Failure.表面活性蛋白 D 与儿童急性呼吸衰竭严重儿科急性呼吸窘迫综合征、长时间通气和死亡相关。
Chest. 2020 Sep;158(3):1027-1035. doi: 10.1016/j.chest.2020.03.041. Epub 2020 Apr 8.
3
Beyond the Alveolar Epithelium: Plasma Soluble Receptor for Advanced Glycation End Products Is Associated With Oxygenation Impairment, Mortality, and Extrapulmonary Organ Failure in Children With Acute Respiratory Distress Syndrome.肺泡上皮以外:血浆可溶性晚期糖基化终产物受体与急性呼吸窘迫综合征患儿氧合损伤、死亡率和肺外器官衰竭相关。
Crit Care Med. 2022 May 1;50(5):837-847. doi: 10.1097/CCM.0000000000005373. Epub 2021 Oct 25.
4
Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury.急性肺损伤患者的血浆表面活性物质蛋白水平与临床结局
Thorax. 2003 Nov;58(11):983-8. doi: 10.1136/thorax.58.11.983.
5
Plasma surfactant protein-D as a diagnostic biomarker for acute respiratory distress syndrome: validation in US and Korean cohorts.血浆表面活性蛋白 D 作为急性呼吸窘迫综合征的诊断生物标志物:美国和韩国队列的验证。
BMC Pulm Med. 2017 Dec 15;17(1):204. doi: 10.1186/s12890-017-0532-1.
6
Impact of Weight Extremes on Clinical Outcomes in Pediatric Acute Respiratory Distress Syndrome.体重极端情况对小儿急性呼吸窘迫综合征临床结局的影响
Crit Care Med. 2016 Nov;44(11):2052-2059. doi: 10.1097/CCM.0000000000001857.
7
Neuromuscular blockade is associated with the attenuation of biomarkers of epithelial and endothelial injury in patients with moderate-to-severe acute respiratory distress syndrome.神经肌肉阻滞与中重度急性呼吸窘迫综合征患者上皮细胞和内皮细胞损伤生物标志物的衰减有关。
Crit Care. 2018 Mar 10;22(1):63. doi: 10.1186/s13054-018-1974-4.
8
Surfactant protein D is a biomarker of influenza-related pediatric lung injury.表面活性蛋白 D 是与流感相关的儿科肺损伤的生物标志物。
Pediatr Pulmonol. 2022 Feb;57(2):519-528. doi: 10.1002/ppul.25776. Epub 2021 Dec 7.
9
Serum Surfactant Protein D as a Biomarker for Measuring Lung Involvement in Obese Patients With Type 2 Diabetes.血清表面活性蛋白D作为衡量2型糖尿病肥胖患者肺部受累情况的生物标志物。
J Clin Endocrinol Metab. 2017 Nov 1;102(11):4109-4116. doi: 10.1210/jc.2017-00913.
10
Association Of Surfactant Protein-D With Obesity.表面活性蛋白-D与肥胖的关联
J Ayub Med Coll Abbottabad. 2016 Jul-Sep;28(3):489-492.

引用本文的文献

1
Circulating Surfactant Protein D: A Biomarker for Acute Lung Injury?循环表面活性蛋白D:急性肺损伤的生物标志物?
Biomedicines. 2023 Sep 12;11(9):2517. doi: 10.3390/biomedicines11092517.
2
Surfactant protein D is a biomarker of influenza-related pediatric lung injury.表面活性蛋白 D 是与流感相关的儿科肺损伤的生物标志物。
Pediatr Pulmonol. 2022 Feb;57(2):519-528. doi: 10.1002/ppul.25776. Epub 2021 Dec 7.
3
Surfactant therapies for pediatric and neonatal ARDS: ESPNIC expert consensus opinion for future research steps.表面活性物质治疗儿科和新生儿急性呼吸窘迫综合征:ESPNIC 专家对未来研究步骤的共识意见。

本文引用的文献

1
Surfactant Protein D Is Associated With Severe Pediatric ARDS, Prolonged Ventilation, and Death in Children With Acute Respiratory Failure.表面活性蛋白 D 与儿童急性呼吸衰竭严重儿科急性呼吸窘迫综合征、长时间通气和死亡相关。
Chest. 2020 Sep;158(3):1027-1035. doi: 10.1016/j.chest.2020.03.041. Epub 2020 Apr 8.
2
A prospective investigation of interleukin-8 levels in pediatric acute respiratory failure and acute respiratory distress syndrome.儿科急性呼吸衰竭和急性呼吸窘迫综合征中白细胞介素-8 水平的前瞻性研究。
Crit Care. 2019 Apr 17;23(1):128. doi: 10.1186/s13054-019-2342-8.
3
Acute respiratory distress syndrome.
Crit Care. 2021 Feb 22;25(1):75. doi: 10.1186/s13054-021-03489-6.
急性呼吸窘迫综合征。
Nat Rev Dis Primers. 2019 Mar 14;5(1):18. doi: 10.1038/s41572-019-0069-0.
4
Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study.儿科急性呼吸窘迫综合征的发病率和流行病学(PARDIE):一项国际性、观察性研究。
Lancet Respir Med. 2019 Feb;7(2):115-128. doi: 10.1016/S2213-2600(18)30344-8. Epub 2018 Oct 22.
5
Interleukin-1 Receptor Antagonist Is Associated With Pediatric Acute Respiratory Distress Syndrome and Worse Outcomes in Children With Acute Respiratory Failure.白细胞介素-1 受体拮抗剂与儿科急性呼吸窘迫综合征相关,并与急性呼吸衰竭患儿的不良结局相关。
Pediatr Crit Care Med. 2018 Oct;19(10):930-938. doi: 10.1097/PCC.0000000000001680.
6
Plasma surfactant protein-D as a diagnostic biomarker for acute respiratory distress syndrome: validation in US and Korean cohorts.血浆表面活性蛋白 D 作为急性呼吸窘迫综合征的诊断生物标志物:美国和韩国队列的验证。
BMC Pulm Med. 2017 Dec 15;17(1):204. doi: 10.1186/s12890-017-0532-1.
7
Association Of Surfactant Protein-D With Obesity.表面活性蛋白-D与肥胖的关联
J Ayub Med Coll Abbottabad. 2016 Jul-Sep;28(3):489-492.
8
Long-Term Pulmonary Function and Quality of Life in Children After Acute Respiratory Distress Syndrome: A Feasibility Investigation.急性呼吸窘迫综合征后儿童的长期肺功能和生活质量:一项可行性调查。
Pediatr Crit Care Med. 2017 Jan;18(1):e48-e55. doi: 10.1097/PCC.0000000000001014.
9
Prediction of non-recovery from ventilator-demanding acute respiratory failure, ARDS and death using lung damage biomarkers: data from a 1200-patient critical care randomized trial.使用肺损伤生物标志物预测需要呼吸机支持的急性呼吸衰竭、急性呼吸窘迫综合征(ARDS)未恢复情况及死亡:一项纳入1200例患者的重症监护随机试验数据
Ann Intensive Care. 2016 Dec;6(1):114. doi: 10.1186/s13613-016-0212-y. Epub 2016 Nov 21.
10
Impact of Weight Extremes on Clinical Outcomes in Pediatric Acute Respiratory Distress Syndrome.体重极端情况对小儿急性呼吸窘迫综合征临床结局的影响
Crit Care Med. 2016 Nov;44(11):2052-2059. doi: 10.1097/CCM.0000000000001857.